The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 10, 2014

Filed:

Dec. 02, 2009
Applicants:

Yan NI, Westfield, NJ (US);

Ayesha Sitlani, Metuchen, NJ (US);

Shilpa Pandit, Edison, NJ (US);

Dale Lewis, Washington Crossing, PA (US);

Xun Shen, Piscataway, NJ (US);

Sharon Lobo, Hackettstown, NJ (US);

Timothy Mccabe, Doylestown, PA (US);

Jon Condra, Doylestown, PA (US);

Rose Cubbon, Fanwood, NJ (US);

Inventors:

Yan Ni, Westfield, NJ (US);

Ayesha Sitlani, Metuchen, NJ (US);

Shilpa Pandit, Edison, NJ (US);

Dale Lewis, Washington Crossing, PA (US);

Xun Shen, Piscataway, NJ (US);

Sharon Lobo, Hackettstown, NJ (US);

Timothy McCabe, Doylestown, PA (US);

Jon Condra, Doylestown, PA (US);

Rose Cubbon, Fanwood, NJ (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/573 (2006.01); G01N 33/543 (2006.01); C07K 16/40 (2006.01);
U.S. Cl.
CPC ...
C07K 16/40 (2013.01); C07K 2317/55 (2013.01); G01N 33/573 (2013.01); G01N 33/543 (2013.01); G01N 2333/96433 (2013.01);
Abstract

Methods of using PCSK9 antagonists More specifically, methods for measuring circulating PCSK9 levels in a biological sample by means of an immunoassay The immunoassay used can be a solid phase immunoassay, such as a dissociation-enhanced lanthanide fluorescence immunoassay utilizing an E07 capture antibody or coating and a G08 or H23 detecting antibody.


Find Patent Forward Citations

Loading…